KANSL1L

Chr 2

KAT8 regulatory NSL complex subunit 1 like

Also known as: C2orf67, MSL1v2

Predicted to enable histone acetyltransferase binding activity. Predicted to be located in intracellular membrane-bounded organelle. Predicted to be part of NSL complex. [provided by Alliance of Genome Resources, Apr 2025]

OMIMResearchGenerating clinical summary…
LOFmechanismLOEUF 0.35
Clinical SummaryKANSL1L
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.66) — some intolerance to loss-of-function variants.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.35LOEUF
pLI 0.657
Z-score 5.25
OE 0.21 (0.130.35)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.25Z-score
OE missense 0.97 (0.901.04)
470 obs / 485.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.21 (0.130.35)
00.351.4
Missense OE?0.97 (0.901.04)
00.61.4
Synonymous OE?1.11
01.21.6
LoF obs/exp: 11 / 51.8Missense obs/exp: 470 / 485.2Syn Z: -1.15

This gene — mechanism propensity

DN
0.4784th %ile
GOF
0.3094th %ile
LOF
0.74top 10%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · LOEUF 0.35

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

KANSL1L · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →